38696-21-8

Basic information

• Product Name: 5-BROMO-2-(DIMETHYLAMINO)PYRIMIDINE
• Synonyms: 5-BROMO-2-(DIMETHYLAMINO)PYRIMIDINE;(5-BROMOPYRIMIDIN-2-YL)DIMETHYLAMINE;5-Bromo-N,N-dimethylpyrimidin-2-amine;2-Pyrimidinamine, 5-bromo-N,N-dimethyl-;2-broMo-N,N-diMethylpyriMidin-4-aMine;5-Bromo-N,N-dimethyl-2-pyrimidinamine;5-Bromo-2-(dimethylamino)pyrimidine 97%
• CAS NO: 38696-21-8
• Molecular Formula: C₆H₈BrN₃
• Molecular Weight: 202.05
• EINECS: 1312995-182-4
• Product Categories: Pyrimidine;Amino;Organohalides;Heterocycle-Pyrimidine series
• Mol File: 38696-21-8.mol
• Article Data: 20

Chemical Properties

• Melting Point: 74-81°C
• Boiling Point: 271.959 °C at 760 mmHg
• Flash Point: 118.277 °C
• Appearance: /
• Density: 1.554 g/cm³
• Vapor Pressure: 0.006mmHg at 25°C
• Refractive Index: 1.599
• Storage Temp.: 2-8°C(protect from light)
• PKA: 2.21±0.10(Predicted)
• CAS DataBase Reference: 5-BROMO-2-(DIMETHYLAMINO)PYRIMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-2-(DIMETHYLAMINO)PYRIMIDINE(38696-21-8)
• EPA Substance Registry System: 5-BROMO-2-(DIMETHYLAMINO)PYRIMIDINE(38696-21-8)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22-36/37/38
• Safety Statements: 26-36/37
• WGK Germany: 3
• Hazardous Substances Data: 38696-21-8(Hazardous Substances Data)

Usage

Chemical Properties

Off-White crystal

InChI:InChI=1/C6H8BrN3/c1-10(2)6-8-3-5(7)4-9-6/h3-4H,1-2H3

Upstream product

• 5621-02-3 2-(dimethylamino)pyrimidine 
• 53939-30-3 5-bromo-2-chloropyridine 
• 124-40-3 dimethyl amine 
• 506-59-2 N,N-dimethylammonium chloride 
• 32779-36-5 5-Bromo-2-chloropyrimidine 
• 7752-82-1 5-bromo-2-aminopyrimidine 
• 74-88-4 methyl iodide 
• 1072-97-5 5-bromo-2-pyridylamine 

Downstream Products

• 184097-42-5 3-(2-(Dimethylamino)-5-pyrimidyl)aniline 
• 1025061-58-8 C₃₅H₄₂ClN₅O₄S 
• 1032759-30-0 N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine-2-amine 
• 1362243-15-9 N₅-(4-(dimethylamino)phenyl)-N₂,N₂-dimethylpyrimidine-2,5-diamine 
• 184174-10-5 N-(3-(2-(Dimethylamino)pyrimid-5-yl)phenyl)-2-amino-4-(1-pyrrolyl)aniline 
• 184173-98-6 N-Acetyl 3-(2-(dimethylamino)-5-pyrimidyl)aniline 
• 1581701-33-8 2-(dimethylamino)-N-(2-methyl-5-((4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)carbamoyl)phenyl)pyrimidine-5-carboxamide 
• 1083329-56-9 5-N-benzylamino-2-N,N-dimethylaminopyrimidine 
• 56621-99-9 5-amino-2-N,N-dimethylaminopyrimidine 
• 1392405-80-9 N²,N²-dimethyl-N⁵-phenylpyrimidine-2,5-diamine 
• 1351597-83-5 C₁₇H₁₇N₅O₂S 
• 55338-76-6 2-(N,N-Dimethylamino)-5-cyanopyrimidin 

Relevant articles and documents

INHIBITORS TO TARGET HIV-1 NEF-CD80/CD86 INTERACTIONS FOR THERAPEUTIC INTERVENTION

The compounds of Formula I, II, and III along with their stereoisomers, pharmaceutically acceptable salts, polymorphs, solvates and hydrates thereof are described in the present disclosure. The said compounds restore immune activation in case of infections or a disease associated with an HIV infection in a subject in need thereof.

SUBSTITUTED BENZAZINONES AS ANTIBACTERIAL COMPOUNDS

The present invention relates to LpxC antibacterial compounds of Formula (1A), corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions:, compound preparation, treatment methods and uses for bacterial infections, especially those caused by gram-negative bacteria.

ANTIOXIDANTS AND METHODS TO MAXIMIZE PERFORMANCE

A method of preventing or reducing the level of degradation of an organic substrate is described, wherein a composition is formed that includes the organic substrate together with an effective amount of a sacrificial base and a diarylamine antioxidant.